Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v10-EN
Language French English
Date Updated 2021-03-10 2021-03-10
Drug Identification Number 02483084 02483084
Brand name SUBLOCADE SUBLOCADE
Common or Proper name Buprenorphine extended release injection Buprenorphine extended release injection
Company Name INDIVIOR UK LIMITED INDIVIOR UK LIMITED
Ingredients BUPRENORPHINE BUPRENORPHINE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION (EXTENDED RELEASE) SOLUTION (EXTENDED RELEASE)
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 syringe/pouch 1 syringe/pouch
ATC code N07BC N07BC
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-09-01 2020-09-01
Actual start date 2020-09-01 2020-09-01
Estimated end date 2021-03-09 2021-03-09
Actual end date 2021-03-09 2021-03-09
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/tier-3-shortages.html https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/tier-3-shortages.html
Health Canada comments